Literature DB >> 2247868

Molecular biology and respiratory disease. 7. The alpha 1 antitrypsin gene and chronic lung disease.

N Kalsheker1, K Morgan.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 2247868      PMCID： PMC462722          DOI： 10.1136/thx.45.10.759

Source DB:  PubMed          Journal:  Thorax        ISSN： 0040-6376            Impact factor:   9.139


× No keyword cloud information.
  41 in total

1.  The Journal of Clinical Epidemiology: same wine, new label for the Journal of Chronic Diseases.

Authors:  A R Feinstein; W O Spitzer
Journal:  J Clin Epidemiol       Date:  1988       Impact factor: 6.437

2.  Alpha 1 -antitrypsin deficiency as an indicator of susceptibility to pulmonary disease.

Authors:  C Mittman; T Barbela; J Lieberman
Journal:  J Occup Med       Date:  1973-01

3.  Prenatal diagnosis of alpha 1-antitrypsin deficiency by direct analysis of the mutation site in the gene.

Authors:  V J Kidd; M S Golbus; R B Wallace; K Itakura; S L Woo
Journal:  N Engl J Med       Date:  1984-03-08       Impact factor: 91.245

4.  A genetic-epidemiologic study of chronic obstructive pulmonary disease. I. Study design and preliminary observations.

Authors:  B H Cohen; W C Ball; W B Bias; S Brashears; G A Chase; E L Diamond; S H Hsu; P Kreiss; D A Levy; H A Menkes; S Permutt; M S Tockman
Journal:  Johns Hopkins Med J       Date:  1975-09

5.  The isolation of a clone for human alpha 1-antitrypsin and the detection of alpha 1-antitrypsin in mRNA from liver and leukocytes.

Authors:  J Rogers; N Kalsheker; S Wallis; A Speer; C H Coutelle; D Woods; S E Humphries
Journal:  Biochem Biophys Res Commun       Date:  1983-10-31       Impact factor: 3.575

Review 6.  Molecular basis of alpha-1-antitrypsin deficiency.

Authors:  M Brantly; T Nukiwa; R G Crystal
Journal:  Am J Med       Date:  1988-06-24       Impact factor: 4.965

7.  Human alpha 1-proteinase inhibitor. Crystal structure analysis of two crystal modifications, molecular model and preliminary analysis of the implications for function.

Authors:  H Loebermann; R Tokuoka; J Deisenhofer; R Huber
Journal:  J Mol Biol       Date:  1984-08-15       Impact factor: 5.469

8.  The amino acid substitutions of human alpha 1-antitrypsin M3, X and Z.

Authors:  J O Jeppsson; C B Laurell
Journal:  FEBS Lett       Date:  1988-04-25       Impact factor: 4.124

9.  A frameshift mutation results in a truncated alpha 1-antitrypsin that is retained within the rough endoplasmic reticulum.

Authors:  R N Sifers; S Brashears-Macatee; V J Kidd; H Muensch; S L Woo
Journal:  J Biol Chem       Date:  1988-05-25       Impact factor: 5.157

10.  Emphysema associated with complete absence of alpha 1- antitrypsin in serum and the homozygous inheritance [corrected] of a stop codon in an alpha 1-antitrypsin-coding exon.

Authors:  K Satoh; T Nukiwa; M Brantly; R I Garver; M Hofker; M Courtney; R G Crystal
Journal:  Am J Hum Genet       Date:  1988-01       Impact factor: 11.025
View more
  2 in total

Review 1.  Genetics and pulmonary medicine. 9. Molecular genetics of chronic obstructive pulmonary disease.

Authors:  P J Barnes
Journal:  Thorax       Date:  1999-03       Impact factor: 9.139

2.  What is Pi (proteinase inhibitor) null or PiQO?: a problem highlighted by the alpha 1 antitrypsin Mheerlen mutation.

Authors:  N Kalsheker; K Hayes; S Weidinger; A Graham
Journal:  J Med Genet       Date:  1992-01       Impact factor: 6.318
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.